Recursion Pharmaceuticals to report Q1 2026 results and host earnings call on May 6

Recursion Pharmaceuticals announced it will release its first quarter 2026 financial results on May 6, 2026, before market open. The company will also provide business updates and hold a public earnings call at 8:00 am ET the same day, accessible via live streams on its social media channels. Recursion is a clinical-stage TechBio company using AI-driven platforms to develop medicines for oncology, rare diseases, and other areas with unmet medical needs. Investors and the public can submit questions ahead of the call. This event is important as it offers insights into the company's progress and financial health amid its innovative drug discovery efforts.